1-6 of 6
Xavier Rialland
Close
Sort by
Journal Articles

Similar Efficacy and Toxicity Profile for Idarubicine and Mitoxantrone in Induction and Intensification Treatment of Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS): Long-Term Results of the EORTC-CLG Randomized Phase III Trial 58921

Barbara De Moerloose, Stefan Suciu, Martine Munzer, Caroline Piette, Karima Yakouben, Genevieve Margueritte, Patrick Lutz, Anne Uyttebroeck, Pierre Rohrlich, MD, PhD, Alina Ferster, Patrick Boutard, Marie-Françoise Dresse, Xavier Rialland, Lucilia Norton, Nicolas Sirvent, Matthias Karrasch, Yves Benoit, MD, Yves Bertrand
Journal: Blood
Blood (2011) 118 (21): 2615.
https://doi.org/10.1182/blood.V118.21.2615.2615
Published: 2011
Journal Articles

Minimal Residual Disease in High and Very High Risk ALL (HR/VHR-ALL) at the End of Induction (EOI) in FRALLE 2000 B and T Protocols.

Jean-Michel Cayuela, PhD, Kheira Beldjord, PhD, Nathalie Grardel, PhD, Hélène Cavé, PhD, Marie-Françoise Auclerc, MD, Anne Auvrignon, MD, Thierry Leblanc, MD, Yves Perel, MD, Françoise Mechinaud, MD, Claudine Schmitt, MD, Virginie Gandemer, MD, Pascale Schneider, MD, Claire Berger, MD, Xavier Rialland, MD, Catherine Paillard, MD, Odile Lejars, MD, Gerard Michel, MD, Guy Leverger, MD, Elizabeth A. Macintyre, MD, PhD, Andre Baruchel, MD
Journal: Blood
Blood (2007) 110 (11): 1427.
https://doi.org/10.1182/blood.V110.11.1427.1427
Published: 2007
Journal Articles

Prognostic Significance of Blasts with/without Pleiocytosis in the Cerebro-Spinal Fluid (CSF) of Children with Acute Lymphoblastic Leukemia (ALL) Treated without Cranial Irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group Study 58881.

Nicolas Sirvent, Stefan Suciu, Xavier Rialland, Alain Robert, Francoise Mazingue, Frederic Millot, Barbara De Moerloose, Alice Ferster, Pierre Rohrlich, Lucilia Norton, Brigitte Lescoeur, Marie-Francoiseçoise Dresse, Patrick Lutz, Liliana Baila, Catherine Behar, Yves Bertrand, Jacques Otten
Journal: Blood
Blood (2006) 108 (11): 149.
https://doi.org/10.1182/blood.V108.11.149.149
Published: 2006
Journal Articles

Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Toxicity and Efficacy Interim Results of the FRALLE 2000-A Protocol.

Andre Baruchel, Anne Auvrignon, Marie-Françoise Auclerc, Yves Perel, Françoise Mechinaud, Virginie Gandemer, Claudine Schmitt, Geneviève Marguerite, Pascale Schneider, Gérard Michel, Christiane Vermylen, Odile Lejars, Christian Berthou, Claire Berger, Catherine Paillard, Gérard Couillault, Brigitte Pautard, Xavier Rialland, Thierry Leblanc, Guy Leverger, the FRALLE group
Journal: Blood
Blood (2004) 104 (11): 1952.
https://doi.org/10.1182/blood.V104.11.1952.1952
Published: 2004
Journal Articles

Comparison of Escherichia coli– asparaginase with Erwinia- asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer—Children's Leukemia Group phase 3 trial

Clinical Trials & Observations
Michel Duval, Stefan Suciu, Alina Ferster, Xavier Rialland, Brigitte Nelken, Patrick Lutz, Yves Benoit, Alain Robert, Anne-Marie Manel, Etienne Vilmer, Jacques Otten, Noël Philippe
Journal: Blood
Blood (2002) 99 (8): 2734–2739.
https://doi.org/10.1182/blood.V99.8.2734
Published: 2002
Journal Articles

Treatment outcome in infant acute lymphoblastic leukemia

Alina Ferster, Yves Benoit, Nadine Francotte, Marie-Françoise Dresse, Anne Uyttebroeck, Emmanuel Plouvier, Antoine Thyss, Patrick Lutz, Geneviève Marguerite, Catherine Behar, Françoise Mazingue, Patrick Boutard, Frederic Millot, Xavier Rialland, Françoise Mechinaud, Lucilia Norton, Alain Robert, Jacques Otten, Etienne Vilmer, Noel Philippe, Christine Waterkeyn, Stefan Suciu
Journal: Blood
Blood (2000) 95 (8): 2729.
https://doi.org/10.1182/blood.V95.8.2729
Published: 2000